Skip to content

Services
Top 50
Events
- Webinars
- Upcoming Events
News & Insights
- Latest Updates
- Branding Partners
About
- Who We Are
- Contact

Menu

Services
Top 50
Events
- Webinars
- Upcoming Events
News & Insights
- Latest Updates
- Branding Partners
About
- Who We Are
- Contact

Search

Close this search box.

Zolgensma

Novartis stands behind Zolgensma® for the treatment of children less than 2 years of age with spinal muscular atrophy

By Featured Partner August 6, 2019

DiversityInc Top 50 Ad Banner

Days

Hours

Minutes

Seconds

Follow us

Linkedin Twitter Instagram Youtube Facebook-f

SUBSCRIBE TODAY!

Get the top DEI news delivered straight to your inbox

Email

Name

Acceptance

DiversityInc is committed to protecting and respecting your privacy. We’ll only use your personal information to administer your account and to provide the products and services you requested from us.
By clicking submit below, you consent to allow DiversityInc to store and process the personal information submitted above to provide you with the content requested.

© Copyright 2022 DiversityInc

Top 50

Overview
Rankings
Methodology
Participate
Assessment Webinars
Media Resources
FAQs

About

Who We Are
Contact

News & Insights

Latest Updates
Featured Partners

Services

Events

MORE

Job Board
Best Practices

Social

Terms of Use
Privacy Policy

Join Our Newsletter

Get the top DEI news delivered straight to your inbox

Your email

First Name

Last Name

Acceptance

DiversityInc is committed to protecting and respecting your privacy. We’ll only use your personal information to administer your account and to provide the products and services you requested from us.
By clicking submit below, you consent to allow DiversityInc to store and process the personal information submitted above to provide you with the content requested.